The Hill, August 8, 2021: FDA news a new focus on public health that protects patient safety and ensures strong scientific evidence. We explain to The Hill that making the right choice is as important as making a decision soon.
Read More »Tag: safety
Beleaguered FDA in talks for drug-company funding
Marketwatch, July 13, 2021: Fees paid by drug companies make up half of the FDA’s revenue. Dr. Diana Zuckerman explains how these fees often influence FDA decisions and sacrifice patient safety.
Read More »Scientific Coalition Letter on Aduhelm to HHS Inspector General, CMS, and Congress
July 7, 2021. As organizations working to promote and protect science for the public good, we are writing to express our concern about the lack of scientific evidence to support the FDA’s recent accelerated approval of Biogen’s Aduhelm (aducanumab) as a drug intended to slow cognitive damage caused by Alzheimer’s disease.
Read More »My breast implants are making me sick — and I’m not alone
Salon, June 20, 2021: It’s not in our heads: More women are speaking up about how their breast implants are making them sick. And Healing Breast Implant Illness Society of North America and National Center for Health Research are making sure women know they are not alone.
Read More »Letter to the Editor: Why Expose Children to the Danger of Artificial Turf Fields
Woodbridge Town News, April 22, 2021. Dr. Zuckerman writes about her concerns for children regarding artificial turf. Currently no tests for the impact of turf on human health are required before getting the product on the market.
Read More »